Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1992 Sep;141(3):531–538.

Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods.

K Beiske 1, A T Myklebust 1, S Aamdal 1, R Langholm 1, E Jakobsen 1, O Fodstad 1
PMCID: PMC1886697  PMID: 1381558

Abstract

An immunocytochemical method, involving four monoclonal antibodies (MAbs) previously selected for their specific binding to small cell lung cancer (SCLC) cells in human bone marrow, was used for detection of bone marrow metastases in 81 patients with diagnosed SCLC. This procedure was compared with two routine morphologic methods with regard to diagnostic efficiency and sensitivity. Bone marrow involvement was found in 26 patients (32%), one of which had limited disease according to conventional clinical criteria. Eight of the positive cases were exclusively diagnosed by immunocytochemistry, whereas the histologic and cytologic methods separately identified two patients each. Immunocytochemistry had a detection level of tumor cells in the mononuclear cell fraction of approximately 1-2%, whereas no patients with less than 10% immunocytologically detectable tumor cells were diagnosed by cytomorphologic examination of bone marrow aspirates. Evidence was obtained that the diagnostic efficiency of any method increased with the number of samples examined. Of the four MAbs used, the anti-NCAM antibody, MOC-1, labeled tumor cells in all immunologically positive patients, and in all but one of these patients all cytologically confirmed tumor cells were stained. The antibodies MOC-31, which recognize a cluster-2 antigen, and NrLu10 bound nearly all tumor cells in most cases, whereas MLuC1 only diagnosed tumor cells in a fraction of the patients. The results show that the immunocytochemical application of these antibodies is superior to morphologic techniques in detecting SCLC bone marrow metastases. Further use of the method might provide prognostically and therapeutically useful information.

Full text

PDF
531

Images in this article

534Figure 1
on p.534
536Figure 3
on p.536

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrams J., Doyle L. A., Aisner J. Staging, prognostic factors, and special considerations in small cell lung cancer. Semin Oncol. 1988 Jun;15(3):261–277. [PubMed] [Google Scholar]
  2. Allan P. M., Garson J. A., Harper E. I., Asser U., Coakham H. B., Brownell B., Kemshead J. T. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer. 1983 May 15;31(5):591–598. doi: 10.1002/ijc.2910310510. [DOI] [PubMed] [Google Scholar]
  3. Berendsen H. H., de Leij L., Postmus P. E., Ter Haar J. G., Poppema S., The T. H. Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen. J Clin Pathol. 1988 Mar;41(3):273–276. doi: 10.1136/jcp.41.3.273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beverley P. C., Olabiran Y., Ledermann J. A., Bobrow L. G., Souhami R. L. Results of the central data analysis. Br J Cancer Suppl. 1991 Jun;14:10–19. [PMC free article] [PubMed] [Google Scholar]
  5. Canon J. L., Humblet Y., Lebacq-Verheyden A. M., Manouvriez P., Bazin H., Rodhain J., Prignot J., Symann M. Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies. Eur J Cancer Clin Oncol. 1988 Feb;24(2):147–150. doi: 10.1016/0277-5379(88)90245-3. [DOI] [PubMed] [Google Scholar]
  6. Fargion S., Carney D., Mulshine J., Rosen S., Bunn P., Jewett P., Cuttitta F., Gazdar A., Minna J. Heterogeneity of cell surface antigen expression of human small cell lung cancer detected by monoclonal antibodies. Cancer Res. 1986 May;46(5):2633–2638. [PubMed] [Google Scholar]
  7. Leonard R. C., Duncan L. W., Hay F. G. Immunocytological detection of residual marrow disease at clinical remission predicts metastatic relapse in small cell lung cancer. Cancer Res. 1990 Oct 15;50(20):6545–6548. [PubMed] [Google Scholar]
  8. Moolenaar C. E., Muller E. J., Schol D. J., Figdor C. G., Bock E., Bitter-Suermann D., Michalides R. J. Expression of neural cell adhesion molecule-related sialoglycoprotein in small cell lung cancer and neuroblastoma cell lines H69 and CHP-212. Cancer Res. 1990 Feb 15;50(4):1102–1106. [PubMed] [Google Scholar]
  9. Myklebust A. T., Beiske K., Pharo A., Davies C. D., Aamdal S., Fodstad O. Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer Suppl. 1991 Jun;14:49–53. [PMC free article] [PubMed] [Google Scholar]
  10. Okabe T., Kaizu T., Fujisawa M., Watanabe J., Kojima K., Yamashita T., Takaku F. Monoclonal antibodies to surface antigens of small cell carcinoma of the lung. Cancer Res. 1984 Nov;44(11):5273–5278. [PubMed] [Google Scholar]
  11. Osterlind K., Ihde D. C., Ettinger D. S., Gralla R. J., Karrer K., Krauss S., Maurer L. H., Rørth M., Sörenson S., Vincent R. Staging and prognostic factors in small cell carcinoma of the lung. Cancer Treat Rep. 1983 Jan;67(1):3–9. [PubMed] [Google Scholar]
  12. Ripamonti M., Canevari S., Ménard S., Mezzanzanica D., Miotti S., Orlandi R., Rilke F., Tagliabue E., Colnaghi M. I. Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model. Cancer Immunol Immunother. 1987;24(1):13–18. doi: 10.1007/BF00199827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stahel R. A., Mabry M., Skarin A. T., Speak J., Bernal S. D. Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol. 1985 Apr;3(4):455–461. doi: 10.1200/JCO.1985.3.4.455. [DOI] [PubMed] [Google Scholar]
  14. Trillet V., Revel D., Combaret V., Favrot M., Loire R., Tabib A., Pages J., Jacquemet P., Bonmartin A., Mornex J. F. Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies. Br J Cancer. 1989 Jul;60(1):83–88. doi: 10.1038/bjc.1989.225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. de Leij L., Poppema S., Nulend J. K., ter Haar A., Schwander E., Ebbens F., Postmus P. E., The T. H. Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. Cancer Res. 1985 May;45(5):2192–2200. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES